Chris Sarchi
Head of Oncology and Transplant
Head of Oncology and Transplant
Mr. Chris Sarchi is responsible for all aspects of marketing and commercialization of oncology and transplant products at Sanofi Genzyme for North America.
Mr. Sarchi joined Sanofi Genzyme in December 2017, following a successful career in the pharmaceutical and biotechnology industry spanning over 25 years. During this time, he held various leadership positions in sales, marketing, strategic planning and new product development, as well as business unit leadership covering multiple therapeutic areas.
Prior to his current role, Mr. Sarchi was the Vice President and BU Head of Oncology and Biosimilars at Boehringer Ingelheim from 2013 to 2018. At BI, he was responsible for the initial build out of the oncology field commercial team. Mr. Sarchi has had additional leadership opportunities and experiences during his time at GSK, as well as Roche/Genentech.
CEO Roundtable on Cancer
Friendraiser
Introduced the CEO Cancer Gold Standard to local business leaders in partnership with Dr. Julio Frenk, Dean of the Faculty, Harvard School of Public Health: Cambridge, MA November 2012
Charles A. Sanders Life Sciences Award Winner
2013 Recipient
CEO Cancer Gold Standard™
Gold Standard Employer
Gold Standard Employer Since 2009 | Gold Standard China Employer Since 2015
Gold Standard Task Force Participation
Chair 2011-2014; Co-Chair 2014-2016: Judy O'Hagan, Vice President Human Resources
Life Sciences Consortium
LSC Task Force Participation
Task Force Member(s): Liz Zhou, MD, Director, North America Medical Affairs
Project Data Sphere, LLC
Data Provider
Staffing and project management support to Project Data Sphere, LLC, 2013-2015
Founding Team Leader Project Data Sphere, LLC: Charles Hugh-Jones, MD, FRCP
Further Support
Chairman CEO Roundtable on Cancer 2011- 2015: Christopher A. Viehbacher, Former CEO, Sanofi
Founding Member, CEO Roundtable on Cancer – China
Provided foundational executive leadership to CEO Roundtable on Cancer – China
Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patient's needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme.
Sanofi US, with headquarters in Bridgewater, New Jersey, employs 17,000 professionals throughout the country. Our affiliate companies in the United States include Genzyme (rare diseases), Sanofi Pasteur (vaccines), Merial (animal health) and Chattem (consumer healthcare).
Through the Sanofi Foundation for North America, we strive to reduce healthcare inequalities in the U.S. by making strategic charitable donations and by establishing partnerships with Non-Government Organizations that have broad expertise in our long-term priorities.
At Sanofi, we act with our partners to protect health, enhance life and respond to the hopes and potential healthcare needs of 7 billion people around the world.